Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells

Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles

(2021) Alena Liskova et al.   EPMA Journal

Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review

(2021) Jasmine Baby et al.   JOURNAL OF FOOD BIOCHEMISTRY

A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma

(2015) Bo Hu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Personalized Radiation Oncology for Breast Cancer: The New Frontier

(2015) Jennifer R. Bellon   JOURNAL OF CLINICAL ONCOLOGY

Codelivery of Sorafenib and Curcumin by Directed Self-Assembled Nanoparticles Enhances Therapeutic Effect on Hepatocellular Carcinoma

(2015) Haiqiang Cao et al.   MOLECULAR PHARMACEUTICS

By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice

(2015) Weiqi Dai et al.   Oncotarget

Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis

(2014) A. Ramírez-Labrada et al.   Clinical & Translational Oncology

Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways

(2014) Arshad H. Rahmani et al.   Evidence-based Complementary and Alternative Medicine

YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma

(2014) Jian Kong et al.   Molecular Cancer

Sorafenib in the treatment of radioiodine-refractory differentiated thyroid cancer: a meta-analysis

(2013) Chen-Tian Shen et al.   ENDOCRINE-RELATED CANCER

Antiproliferative effects of sorafenib and pegylated IFN-α2b on human liver cancer cells in vitro and in vivo

(2013) HIRONORI KUSANO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Superior antimitogenic and chemosensitization activities of the combination treatment of the histone deacetylase inhibitor apicidin and proteasome inhibitors on human colorectal cancer cells

(2013) MOHAMED-SALAH I. ABAZA et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer

(2013) Y. B. Kim et al.   JOURNAL OF RADIATION RESEARCH

Quercetin and Sorafenib as a Novel and Effective Couple in Programmed Cell Death Induction in Human Gliomas

(2013) Joanna Jakubowicz-Gil et al.   NEUROTOXICITY RESEARCH

Combined anti-tumor effects of IFN-α and sorafenib on hepatocellular carcinoma in vitro and in vivo

(2012) Lijing Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy

(2012) Thomas C. Wehler et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma

(2012) Xiangxuan Zhao et al.   LABORATORY INVESTIGATION

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

(2012) Wing-Kin Sung et al.   NATURE GENETICS

Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo

(2011) Yu-Cheng Kuo et al.   BIOMEDICINE & PHARMACOTHERAPY

Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model

(2011) J S P Yuen et al.   BRITISH JOURNAL OF CANCER

Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives

(2011) Chia-Jui Weng et al.   CANCER TREATMENT REVIEWS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer

(2011) Lucia Migliore et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Role of Bcl-2 family proteins and caspases in the regulation of apoptosis

(2011) Mohammad Shamsul Ola et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics

(2010) Vanessa Rausch et al.   CANCER RESEARCH

A natural compound, methyl angolensate, induces mitochondrial pathway of apoptosis in Daudi cells

(2010) Kishore K. Chiruvella et al.   INVESTIGATIONAL NEW DRUGS

Sorafenib suppresses the cell cycle and induces the apoptosis of hepatocellular carcinoma cell lines in serum-free media

(2010) MINORU TOMIZAWA et al.   Experimental and Therapeutic Medicine

Evolving Treatment of Advanced Colon Cancer

(2009) Neil H. Segal et al.   Annual Review of Medicine

Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention

(2009) Vidushi S. Neergheen et al.   TOXICOLOGY

Signal-dependent regulation of gene expression as a target for cancer treatment: Inhibiting p38α in colorectal tumors

(2008) Fulvio Chiacchiera et al.   CANCER LETTERS

Apoptosis and non-apoptotic deaths in cancer development and treatment response

(2008) Elza C. de Bruin et al.   CANCER TREATMENT REVIEWS

How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?

(2008) Jerry E. Chipuk et al.   TRENDS IN CELL BIOLOGY

Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise

(2007) Naghma Khan et al.   ANTIOXIDANTS & REDOX SIGNALING